Moderna, Inc. (0A45)
LSE
Closed
Aug 21, 2026
Day's Range
131.0052 wk Range
22.25Overview - 0A45 - Moderna, Inc.
Key Statistics
Valuation
Enterprise Value
23.28B
P/E (Trailing)
‪55.33‬
PEG Ratio
‪-7.36‬
Price / Sales (TTM)
‪6.76‬
Price / Book
‪3.33‬
EV / EBITDA
‪26.58‬
Profitability
Gross Margin
‪34.96%‬
Profit Margin
‪11.32%‬
Operating Margin
‪4.81%‬
Return on Assets
‪1.33%‬
Return on Equity
‪6.91%‬
Ownership
Shares Outstanding
399.00M
Float
343.43M
Held by Insiders
‪9.68%‬
Held by Institutions
‪69.48%‬
Price stats
Beta
‪1.64‬
50-Day Avg
‪65.86‬
200-Day Avg
‪48.80‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 0A45 - Moderna, Inc.
Peers - 0A45 - Moderna, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on LSE.
- 0A45LSEModerna, Inc.72.10BMarket Cap+82.56%52-week change58.46P/E (Trailing)‪11.32%‬Profit Margin
- 0MGBLSEGenmab A/S173.69BMarket Cap+27.59%52-week change30.44P/E (Trailing)‪29.01%‬Profit Margin
- 0QZULSEVertex Pharmaceuticals Incorporated140.34BMarket Cap+29.12%52-week change0.58P/E (Trailing)‪34.99%‬Profit Margin
- 0R2MLSERegeneron Pharmaceuticals, Inc.90.49BMarket Cap+31.55%52-week change0.12P/E (Trailing)‪27.86%‬Profit Margin
- 0QW0LSEargenx SE52.61BMarket Cap+34.75%52-week change42.42P/E (Trailing)‪-47.51%‬Profit Margin
- 0NZTLSEUCB SA44.92BMarket Cap+9.47%52-week change128.71P/E (Trailing)‪6.45%‬Profit Margin
- 0K91LSENorthern Trust Corporation40.97BMarket Cap+29.60%52-week change0.26P/E (Trailing)‪24.67%‬Profit Margin
Profile Summary - 0A45 - Moderna, Inc.
About
Moderna, Inc. is a biotechnology company specializing in the development of transformative medicines using messenger ribonucleic acid (mRNA) technology. Its primary focus lies in creating innovative therapeutics across multiple modalities, including prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
